IP Library Granted Patent US 8,846,342
Granted Patent B2
US 8,846,342 · App. 13/510,859 · Granted Sep 30, 2014

Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells

Inventors: Michael Wacker (Unterengstringen, CH); Charles Waechter (Lexington, KY)
Assignee: GlycoVaxyn AG
A61K39/0283A61K39/385
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,846,342
App. No.
13/510,859
Granted
Sep 30, 2014
Kind
B2
Abstract

The invention is directed to bioconjugate vaccines comprising N-glycosylated proteins. Further, the present invention is directed to a recombinant prokaryotic biosynthetic system comprising nucleic acids encoding an epimerase that synthesizes an oligo- or polysaccharide having N-acetylgalactosamine at the reducing terminus. The invention is further directed to N-glycosylated proteins containing an oligo- or polysaccharide having N-acetylgalactosamine at the reducing terminus and an expression system and methods for producing such N-glycosylated proteins.

Claims (30)

1. A recombinant prokaryotic biosynthetic system comprising:

(i) a nucleic acid encoding an epimerase that synthesizes N-acetylgalactosamine on undecaprenyl pyrophosphate, wherein said epimerase comprises the amino acid sequence of SEQ ID NO. 2;

(ii) a nucleic acid encoding a glycosyltransferase that participates in the assembly of an oligo- or polysaccharide on a lipid carrier;

(iii) a nucleic acid encoding an oligosaccharyl transferase; and

(iv) a nucleic acid encoding a protein comprising one or more of an introduced consensus sequence, D/E-X-N-Z-S/T (SEQ ID NO:31), wherein X and Z can be any natural amino acid except proline.

2. The recombinant prokaryotic biosynthetic system of claim 1 , wherein said oligosaccharyl transferase is from Campylobacter jejuni.

3. The recombinant prokaryotic biosynthetic system of claim 1 , wherein said protein is P. aeruginosa exoprotein.

4. The recombinant prokaryotic biosynthetic system of claim 1 , wherein said oligo- or polysaccharide is from a Gram-negative bacterium.

5. The recombinant prokaryotic biosynthetic system of claim 4 , wherein said oligo- or polysaccharide is from Shigella flexneri.

6. The recombinant prokaryotic biosynthetic system of claim 5 , wherein said oligo- or polysaccharide is from Shigella flexneri 6.

7. The recombinant prokaryotic biosynthetic system of claim 1 , wherein said oligo- or polysaccharide comprises a structure:

8. The recombinant prokaryotic biosynthetic system of claim 4 , wherein said oligo- or polysaccharide is from E. coli.

9. The recombinant prokaryotic biosynthetic system of claim 8 , wherein said oligo- or polysaccharide is from E. coli 0157.

10. The recombinant prokaryotic biosynthetic system of claim 1 , wherein said oligo- or polysaccharide comprises a structure, α-D-PerNAc-α-L-Fuc-β-D-Glc-α-D-GalNAc.

11. A method of producing an N-linked glycosylated protein, comprising:

a.) introducing into a host organism:

i.) a nucleic acid encoding an epimerase that synthesizes N-acetylgalactosamine on undecaprenyl pyrophosphate, wherein said epimerase comprises the amino acid sequence of SEQ ID NO. 2;

ii.) a nucleic acid encoding a glycosyltransferase that participates in the assembly of an oligo- or polysaccharide on a lipid carrier;

iii.) a nucleic acid encoding an oligosaccharyl transferase; and

iv.) a nucleic acid encoding a protein comprising one or more of an introduced consensus sequence, D/E-X-N-Z-S/T (SEQ ID NO:31), wherein X and Z can be any natural amino acid except proline; and

b.) culturing said host organism until at least one N-glycosylated protein is produced.

12. The method of claim 11 , wherein said oligosaccharyl transferase is from Campylobacter jejuni.

13. The method of claim 11 , wherein said protein is P. aeruginosa exoprotein.

14. The method of claim 11 , wherein said oligo- or polysaccharide is from a Gram-negative bacterium.

15. The method of claim 14 , wherein said oligo- or polysaccharide is from Shigella flexneri.

16. The method of claim 15 , wherein said oligo- or polysaccharide is from Shigella flexneri 6.

17. The method of claim 11 , wherein said oligo- or polysaccharide comprises a structure:

18. The method of claim 14 , wherein said oligo- or polysaccharide is from E. coli.

19. The method of claim 18 , wherein said oligo- or polysaccharide is from E. coli 0157.

20. The method of claim 11 , wherein said oligo- or polysaccharide comprises a structure, α-D-PerNAc-α-L-Fuc-β-D-Glc-α-D-GalNAc.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2018
From: GLYCOVAXYN AG
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 046558/0593 →
Continuity (2)
Provisional Application 61272931 · Nov 19, 2009
Related Publication 20130028926A1 · Jan 31, 2013